As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts!
The COVID-19 pandemic has affected treatment planning and shared decision-making for individuals with chronic lymphocytic leukemia. In this episode, we'll discuss how patient education has become even more critical as the pandemic recedes and restrictions loosen.
Hear specific tactics to help patients better retain and ensure understanding of what is communicated during their education appointments, and effective practices to support patients with CLL through this new world of uncertainty.
“When very strict regulations were in place, patients tended to feel safe staying at home, limiting any sort of exposure. Now that some of these regulations have loosened, many patients are confused or uncertain of that safety, of that "returning to usual.”
Marie Sirek, PharmD, BCACP, CPP
Clinical Pharmacy Specialist I Oral Oncology;
Interim Lead – Ambulatory Care Pharmacy
Billings Clinic, Billings, Montana
This podcast is part of the “Returning to Practice in the Post-COVID-19 Era: Resources for Treating Chronic Lymphocytic Leukemia” education program. Funding & support provided by AbbVie.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
